PL3482209T3 - Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii - Google Patents

Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii

Info

Publication number
PL3482209T3
PL3482209T3 PL17742509.7T PL17742509T PL3482209T3 PL 3482209 T3 PL3482209 T3 PL 3482209T3 PL 17742509 T PL17742509 T PL 17742509T PL 3482209 T3 PL3482209 T3 PL 3482209T3
Authority
PL
Poland
Prior art keywords
alpha
synucleinopathies
diagnosing
detection assay
synuclein
Prior art date
Application number
PL17742509.7T
Other languages
English (en)
Inventor
Alison Green
Graham FAIRFOUL
Original Assignee
The University Court Of The University Of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Court Of The University Of Edinburgh filed Critical The University Court Of The University Of Edinburgh
Publication of PL3482209T3 publication Critical patent/PL3482209T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7047—Fibrils-Filaments-Plaque formation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL17742509.7T 2016-07-07 2017-07-06 Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii PL3482209T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1611840.8A GB201611840D0 (en) 2016-07-07 2016-07-07 Alpha-synuclein detection assay
PCT/GB2017/051988 WO2018007817A1 (en) 2016-07-07 2017-07-06 Alpha-synuclein detection assay and method for diagnosing alpha-synucleinopathies

Publications (1)

Publication Number Publication Date
PL3482209T3 true PL3482209T3 (pl) 2024-04-08

Family

ID=56890945

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17742509.7T PL3482209T3 (pl) 2016-07-07 2017-07-06 Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii

Country Status (11)

Country Link
US (4) US11099197B2 (pl)
EP (3) EP4321871A3 (pl)
JP (1) JP6980750B2 (pl)
KR (1) KR102323688B1 (pl)
CN (2) CN116930506A (pl)
AU (2) AU2017292377B2 (pl)
ES (1) ES2964810T3 (pl)
GB (1) GB201611840D0 (pl)
HR (1) HRP20231592T1 (pl)
PL (1) PL3482209T3 (pl)
WO (2) WO2018007817A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12265089B2 (en) 2014-09-11 2025-04-01 Board Of Regents Of The University Of Texas System Discriminating Parkinson's disease from multiple system atrophy using alpha-synuclein PMCA
GB201611840D0 (en) * 2016-07-07 2016-08-24 Univ Court Of The Univ Of Edinburgh The Alpha-synuclein detection assay
GB201720970D0 (en) 2017-12-15 2018-01-31 Ucb Biopharma Sprl Antibodies
GB201720975D0 (en) 2017-12-15 2018-01-31 Ucb Biopharma Sprl Anti-alpha synuclein antibodies
GB201803553D0 (en) * 2018-03-06 2018-04-18 Univ Newcastle Detection of pathological protein aggregation
KR102069435B1 (ko) * 2018-03-27 2020-02-24 성균관대학교산학협력단 콧물액을 이용한 파킨슨 질환의 진단 방법, 이를 위한 조성물 및 이를 포함하는 키트
US12099070B2 (en) 2019-02-05 2024-09-24 Osaka University Method and kit for discriminating between parkinson's disease and multiple system atrophy
EP3947718A4 (en) * 2019-04-02 2022-12-21 Enumera Molecular, Inc. METHODS, SYSTEMS AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES
AU2020266589A1 (en) * 2019-04-30 2021-10-28 Chase Therapeutics Corporation Alpha-synuclein assays
JP7376040B2 (ja) * 2019-09-03 2023-11-08 国立大学法人京都工芸繊維大学 神経変性疾患におけるバイオマーカー分子の検出方法
IL291067B1 (en) * 2019-09-04 2026-05-01 Amprion Inc Detection of alpha-synuclein using beads
US20220390443A1 (en) * 2019-11-11 2022-12-08 Oxford University Innovation Limited Method of isolating a selected population of exosomes
KR102277871B1 (ko) * 2019-12-17 2021-07-15 원광대학교산학협력단 소변의 알파-씨누클레인 중합체 측정에 의한 파킨슨병 진단 정보의 수집방법 및 그 키트
US20210223268A1 (en) * 2020-01-21 2021-07-22 Board Of Regents Of The University Of Texas System Discriminating parkinson's disease from multiple system atrophy using alpha-synuclein pmca
KR102466943B1 (ko) 2020-04-02 2022-11-14 한국과학기술연구원 갭을 갖는 바이오 센서를 이용한 파킨슨병 모니터링 방법 및 시스템
KR102376482B1 (ko) * 2020-08-21 2022-03-17 재단법인대구경북과학기술원 병원성 알파-시누클린 응집체의 씨딩 활성 유도 및 정량분석 방법
MX2023014511A (es) * 2021-06-07 2024-04-16 Univ Minnesota Metodos y materiales para detectar enfermedades prionicas.
WO2022270901A1 (ko) * 2021-06-25 2022-12-29 장재원 동적 형광 또는 x-선의 표준편차와 자기상관을 활용한 조기 진단 시스템
CN115032400A (zh) * 2022-03-28 2022-09-09 首都医科大学附属北京天坛医院 α-突触核蛋白在辅助诊断神经退行性疾病中的用途
CN115043927B (zh) * 2022-06-17 2024-03-19 武汉大学 针对抗α-突触核蛋白K80Hcy抗体的抗原肽及其应用
WO2024089232A1 (en) 2022-10-28 2024-05-02 Stavanger University Hospital Alpha-synuclein detection assay comprising zinc ions in the reaction mixture and method for diagnosing alpha-synucleinopathies
WO2024144287A1 (ko) * 2022-12-30 2024-07-04 재단법인대구경북과학기술원 알파시누클레인에 의한 혈액-뇌장벽 손상 진단용 마커 및 이의 용도
WO2025097367A1 (zh) * 2023-11-09 2025-05-15 首都医科大学附属北京天坛医院 种子扩增法检测口腔粘膜来源α-突触核蛋白在辅助诊断神经退行性疾病中的用途
EP4682539A1 (en) * 2024-07-15 2026-01-21 Modag GmbH Method for detecting misfolded alpha-synuclein protein in biological samples to determine the presence of synucleinopathies in an individual
CN121276061B (zh) * 2025-09-22 2026-05-01 首都医科大学宣武医院 淀粉样蛋白聚集体的检测试剂、检测试剂盒及检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE311199T1 (de) 1999-05-07 2005-12-15 Genentech Inc Behandlung von autoimmunkrankheiten mit antagonisten die oberflächenmarker von b zellen binden
WO2004073651A2 (en) 2003-02-18 2004-09-02 The Ohio State University Research Foundation Identifying inhibitors of intracellular protein fibrillization
WO2010000372A2 (en) * 2008-06-09 2010-01-07 Ludwig-Maximilians-Universität München New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
US10989718B2 (en) * 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US9588129B2 (en) 2013-03-15 2017-03-07 Amira Medical Technologies Inc. Methods for analyzing blood to detect diseases associated with abnormal protein aggregation
EP3191599B1 (en) * 2014-09-11 2023-08-02 Board Of Regents Of the University Of Texas System Detection of misfolded proteins
GB201611840D0 (en) * 2016-07-07 2016-08-24 Univ Court Of The Univ Of Edinburgh The Alpha-synuclein detection assay
CA3074914A1 (en) * 2017-10-02 2019-04-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Assay for the detection of alpha-synuclein seeding activity associated with synucleinopathies
US11356684B2 (en) 2019-08-30 2022-06-07 Alibaba Group Holding Limited Method and system for signaling chroma quantization parameter table
IL291067B1 (en) * 2019-09-04 2026-05-01 Amprion Inc Detection of alpha-synuclein using beads

Also Published As

Publication number Publication date
WO2018007817A1 (en) 2018-01-11
NZ750096A (en) 2025-09-26
EP3482209C0 (en) 2023-11-15
CN109496272B (zh) 2023-07-25
GB201611840D0 (en) 2016-08-24
EP3482209A1 (en) 2019-05-15
US11099197B2 (en) 2021-08-24
EP4321871A2 (en) 2024-02-14
CN116930506A (zh) 2023-10-24
JP2019527353A (ja) 2019-09-26
AU2023229490A1 (en) 2025-03-27
US20250027957A1 (en) 2025-01-23
US20190302128A1 (en) 2019-10-03
US11360103B2 (en) 2022-06-14
HRP20231592T1 (hr) 2024-03-15
EP4733767A2 (en) 2026-04-29
ES2964810T3 (es) 2024-04-09
AU2017292377B2 (en) 2023-06-15
US12078643B2 (en) 2024-09-03
KR102323688B1 (ko) 2021-11-08
KR20190027847A (ko) 2019-03-15
WO2025052171A1 (en) 2025-03-13
CA3029204A1 (en) 2018-01-11
JP6980750B2 (ja) 2021-12-15
EP4321871A3 (en) 2024-05-08
US20210263049A1 (en) 2021-08-26
EP3482209B1 (en) 2023-11-15
AU2017292377A1 (en) 2019-02-07
CN109496272A (zh) 2019-03-19
US20210405069A1 (en) 2021-12-30

Similar Documents

Publication Publication Date Title
IL289907A (en) Methods and systems for identification and analysis of tested material
IL265396A (en) Methods and compositions for detecting analytes
IL258804B (en) Systems and methods for adaptive detection - area of defects
GB201611840D0 (en) Alpha-synuclein detection assay
ZA201801630B (en) Methods for diagnosing and evaluating non-alcoholic steatohepatitis
PL3543880T3 (pl) Układ do diagnozowania i rokowania w przypadku udaru mózgu
GB201621514D0 (en) Padlock probe detection method
IL258063A (en) Test system and test method
IL251440B (en) Methods and systems for identifying analytes
HUE047156T2 (hu) Peptidek, eszközök és eljárások Anaplasma-ellenanyagok kimutatására
GB201717399D0 (en) Proteogenomic analysis system and methods
EP3117213A4 (en) System and method for lateral flow immunoassay testing
IL250402B (en) A method for detecting sickle cell disease and its application
GB201515693D0 (en) Method for antigen detection
SG11201708795TA (en) Analyte detection and methods therefor
PL3440364T3 (pl) Układ i sposób do badania materiałów
EP3379255A4 (en) Detection method, detection device, and inspection kit
GB201619509D0 (en) Sample detection device
GB201409093D0 (en) An immunoassay detection device
SG10202006588UA (en) Methods and systems for experiment design and analysis
IL261734A (en) A method for detection and means for it
GB201404296D0 (en) Systems and methods for testing sensor units
PT3165907T (pt) Métodos e sistemas para testes não destrutivos
GB201705764D0 (en) Analyte detection method
GB201515355D0 (en) A method and kit for analyte detection